News

The CMO of RxAdvance weighs in on what the next phase of big deals signals for the industry's future.

As the big data revolution continues to rock the healthcare space, there are still questions about how to get a handle on that massive amount of data and make it valuable.

Medication management and adherence app maker Medisafe has announced a partnership with Boehringer Ingelheim following a successful pilot.

Behavioral health technology company AbleTo has raised an additional $8.

Submissions for speaking opportunities at the health IT conference are open until July 16, 2018.

Mightier, a Boston Children’s Hospital spinout that makes biofeedback video games to help children with emotional regulation, has raised $2.

At long last, Eversense, the implantable continuous glucose monitoring system from Senseonics, has received FDA clearance to be marketed in the United States.

Children with Type 1 diabetes will now have access to the Medtronic MiniMed 670G, a hybrid closed-loop system insulin delivery system, following the FDA’s decision to expand the product approval for a younger demographic.

Finding time to get tested.

Glucose-monitoring contact lenses have been a continuing area of interest from developers all over the world.